Updated:
Flare Capital Partners
Flare Capital Partners is the leading healthcare technology venture capital firm advancing innovation-driven companies to improve positive health...
Flare Capital Partners
Flare Capital Partners is the leading healthcare technology venture capital firm advancing innovation-driven companies to improve positive health outcomes, broaden care access, and lower healthcare costs. We partner with exceptional founders solving healthcare’s hardest challenges, supporting each with our deep sector expertise, unparalleled industry resources, and proven access to commercial opportunities. Our team of established investors and senior operating executives has invested in 70+ companies and has nearly $1 billion in assets under management. To learn more about Flare Capital Partners, please visit flarecapital.com or follow us on YouTube @flarecapitalpartners, Spotify, or Twitter @flarecapital.
General information
Firm type
Private Equity
Year founded
—
AUM
~$1B (per firm website)
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
San Francisco, CA · New York, NY · Nashville, TN · Salt Lake City, UT
Principals
Adam Bruce
Partner, Chief Financial and Chief Operating Officer
Ian Chiang
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Flare Capital Partners?
The firm's publicly listed investment team is led by Partners Ian Chiang and Adam Bruce, according to the firm's website. Adam Bruce additionally serves as Chief Financial and Chief Operating Officer. The team includes investors with operational, clinical, and technology backgrounds, reflecting the firm's focus on early-stage and growth-stage healthtech.
How does Flare Capital Partners source proprietary deal flow?
Flare leans on an Industry Advisory Board of senior healthcare executives, an AI Advisory Council, and its Flare Scholars network of 509 graduate students and rising professionals. These groups provide early visibility into emerging founders, clinical-use cases, and technology shifts inside health systems, which the firm translates into investment opportunities and co-creation projects.
What investment stages does Flare Capital Partners typically target?
Flare invests across seed, start-up, early-stage, growth, and expansion-stage rounds. The firm also launches proprietary co-creations, where it incubates healthtech companies alongside founders from concept. This combines a traditional venture-stage approach with an active company-formation practice.
Which sectors does Flare Capital focus on, and does it explicitly avoid any areas?
Flare concentrates on the technology infrastructure layer of healthcare, including AI, software, and data platforms. The firm has backed clinical intelligence, AI-driven clinical documentation, and weight-inclusive care platforms. It does not publicly state explicit avoidance categories, but its portfolio and messaging suggest it stays within healthtech and does not pursue general enterprise SaaS or therapeutics.
Does Flare Capital Partners maintain adjacent vehicles or philanthropic structures?
Flare runs the Flare Scholars Program, a talent-development community that gives graduate students hands-on venture experience, but no separate philanthropic foundation or charitable vehicle is disclosed. The program serves as both a pipeline for talent and a network node, without a separate 501(c)(3) structure listed publicly.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: